A detailed history of Data Collective Iv Gp, LLC transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Data Collective Iv Gp, LLC holds 5,941,120 shares of RXRX stock, worth $39.4 Million. This represents 53.46% of its overall portfolio holdings.

Number of Shares
5,941,120
Previous 5,941,120 -0.0%
Holding current value
$39.4 Million
Previous $59.2 Million 24.77%
% of portfolio
53.46%
Previous 51.78%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

BUY
$16.14 - $21.86 $95.9 Million - $130 Million
5,941,120 New
5,941,120 $102 Million

Others Institutions Holding RXRX

About RECURSION PHARMACEUTICALS, INC.


  • Ticker RXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 180,480,000
  • Market Cap $1.2B
  • Description
  • Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...
More about RXRX
Track This Portfolio

Track Data Collective Iv Gp, LLC Portfolio

Follow Data Collective Iv Gp, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Data Collective Iv Gp, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Data Collective Iv Gp, LLC with notifications on news.